These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 1385521

  • 1. Neuropeptides modulate human eosinophil chemotaxis.
    Numao T, Agrawal DK.
    J Immunol; 1992 Nov 15; 149(10):3309-15. PubMed ID: 1385521
    [Abstract] [Full Text] [Related]

  • 2. Triple role of platelet-activating factor in eosinophil migration across monolayers of lung epithelial cells: eosinophil chemoattractant and priming agent and epithelial cell activator.
    Liu L, Zuurbier AE, Mul FP, Verhoeven AJ, Lutter R, Knol EF, Roos D.
    J Immunol; 1998 Sep 15; 161(6):3064-70. PubMed ID: 9743372
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
    Wardlaw AJ, Moqbel R, Cromwell O, Kay AB.
    J Clin Invest; 1986 Dec 15; 78(6):1701-6. PubMed ID: 3023451
    [Abstract] [Full Text] [Related]

  • 7. Eosinophils isolated by magnetic cell sorting respond poorly to lipid chemoattractants.
    Casale TB, Erger RA, Rozell MD.
    Ann Allergy Asthma Immunol; 1999 Aug 15; 83(2):127-31. PubMed ID: 10480585
    [Abstract] [Full Text] [Related]

  • 8. Platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils.
    Fukuda T, Numao T, Akutsu I, Makino S.
    J Lipid Mediat; 1992 Aug 15; 5(2):145-9. PubMed ID: 1525356
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Eosinophil chemotaxis induced by several biologically active substances and the effects of apafant on it in vitro.
    Nabe T, Yamamura H, Kohno S.
    Arzneimittelforschung; 1997 Oct 15; 47(10):1112-6. PubMed ID: 9368704
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of human eosinophil chemotaxis in vitro by the anti-allergic agent emedastine difumarate.
    el-Shazly AE, Masuyama K, Samejima Y, Eura M, Ishikawa T.
    Immunopharmacol Immunotoxicol; 1996 Nov 15; 18(4):587-95. PubMed ID: 8933171
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Platelet-activating factor-induced human eosinophil transendothelial migration: evidence for a dynamic role of the endothelium.
    Casale TB, Erger RA, Little MM.
    Am J Respir Cell Mol Biol; 1993 Jan 15; 8(1):77-82. PubMed ID: 8380250
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Tumor necrosis factor alpha induces migration of human eosinophils.
    Nagata M, Fukuda T, Numao T, Makino S, Dohi Y.
    Arerugi; 1993 Apr 15; 42(4):549-55. PubMed ID: 8323453
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparative studies indicate that platelet-activating factor is a relatively weak eosinophilotactic mediator.
    Erger RA, Casale TB.
    Am J Respir Cell Mol Biol; 1995 Jan 15; 12(1):65-70. PubMed ID: 7811471
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.